Ocular Drug Delivery Technologies

Ocular Drug Delivery Technology Market (Technology - Topical, Ocular Inserts (Non-Erodible and Erodible), Iontophoresis, Intraocular Implants (Biodegradable and Non-Biodegradable), and In Situ Gel & Punctal Plugs; Formulation Type - Suspension, Solution, Emulsion, Liposomes & Nanoparticles, and Ointments; Disease Type - Glaucoma, Diabetic Retinopathy, Macular Degeneration, Diabetic Macular Edema, and Cataract; End User - Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics, and Homecare Settings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Rep Id : TMRGL2869
  • Published On : Jul 2017
  • No. of Pages : 214
  • Category : Pharmaceutical

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Ocular Drug Delivery Disease Type Market

4. Market Overview
     4.1. Introduction
             4.1.1. Disease Type Definition
             4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Key Market Indicators
             4.3.1. Region/Country Specific
             4.3.2. Product/Application/Disease Type Specific
             4.3.3. Target Market Specific – Global Scenario
     4.4. Market Dynamics
             4.4.1. Drivers
             4.4.2. Restraints
             4.4.3. Opportunity
     4.5. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, 2015–2025
     4.6. Ocular Drug Delivery Disease Type Market - Global Supply Demand Scenario
     4.7. Porter’s Five Force Analysis
     4.8. Market Outlook
     4.9. Ocular Drug Delivery Technology: Pipeline Analysis

5. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Disease Type 
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value Forecast By Disease Type , 2015–2025
             5.4.1. Topical
             5.4.2. Ocular Insert
                        5.4.2.1. Erodible
                        5.4.2.2. Non-Erodible
             5.4.3. Iontophoresis
             5.4.4. Intraocular Implant
                        5.4.4.1. Biodegradable 
                        5.4.4.2. Non-Biodegradable
             5.4.5. In Situ Gel & Punctal Plug
             5.4.6. Others
     5.5. Market Attractiveness By Disease Type 

6. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Formulation Type 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value Forecast By Formulation Type , 2015–2025
             6.4.1. Solution
             6.4.2. Suspension
             6.4.3. Emulsion
             6.4.4. Liposomes & Nanoparticles
             6.4.5. Ointments
     6.5. Market Attractiveness By Formulation Type 

7. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Disease Type 
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Key Trends
     7.4. Market Value Forecast By Disease Type , 2015–2025
             7.4.1. Diabetic Retinopathy
             7.4.2. Macular Degeneration
             7.4.3. Cataract
             7.4.4. Glaucoma
             7.4.5. Diabetic Macular Edema
             7.4.6. Dry Eye Syndrome
             7.4.7. Others
     7.5. Market Attractiveness By Disease Type 

8. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By End User 
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Key Trends
     8.4. Market Value Forecast By End User , 2015–2025
             8.4.1. Hospitals
             8.4.2. Ambulatory Surgical Centers
             8.4.3. Ophthalmic Clinics
             8.4.4. Homecare Settings
     8.5. Market Attractiveness By End User 

9. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Region
     9.1. Key Findings
     9.2. Policies and Regulations
     9.3. Market Value Forecast By Region
             9.3.1. North America 
             9.3.2. Europe 
             9.3.3. Asia Pacific 
             9.3.4. Latin America 
             9.3.5. Middle East & Africa 
     9.4. Market Attractiveness By Country/Region

10. North America Ocular Drug Delivery Disease Type Market Analysis and Forecast
     10.1. Introduction
             10.1.1. Key Findings
             10.1.2. Policies and Regulations
             10.1.3. Price Trend Analysis
             10.1.4. Key Trends
     10.2. Market Value Forecast By Disease Type , 2015–2025
             10.2.1. Topical
             10.2.2. Ocular Insert
                        10.2.2.1. Erodible
                        10.2.2.2. Non-Erodible
             10.2.3. Iontophoresis
             10.2.4. Intraocular Implant
                        10.2.4.1. Biodegradable 
                        10.2.4.2. Non-Biodegradable
             10.2.5. In Situ Gel & Punctal Plug
             10.2.6. Others
     10.3. Market Value Forecast By Formulation Type , 2015–2025
             10.3.1. Solution
             10.3.2. Suspension
             10.3.3. Emulsion
             10.3.4. Liposomes & Nanoparticles
             10.3.5. Ointments
     10.4. Market Value Forecast By Disease Type , 2015–2025
             10.4.1. Diabetic Retinopathy
             10.4.2. Macular Degeneration
             10.4.3. Cataract
             10.4.4. Glaucoma
             10.4.5. Diabetic Macular Edema
             10.4.6. Dry Eye Syndrome
             10.4.7. Others
     10.5. Market Value Forecast By End User , 2015–2025
             10.5.1. Hospitals
             10.5.2. Ambulatory Surgical Centers
             10.5.3. Ophthalmic Clinics
             10.5.4. Homecare Settings
     10.6. Market Value Forecast By Country , 2015–2025
             10.6.1. U.S.
             10.6.2. Canada
     10.7. Market Attractiveness Analysis 
             10.7.1. By Disease Type 
             10.7.2. By Formulation Type 
             10.7.3. By Disease Type 
             10.7.4. By End User 
             10.7.5. By Country

11. Europe Ocular Drug Delivery Disease Type Market Analysis and Forecast
     11.1. Introduction
             11.1.1. Key Findings
             11.1.2. Policies and Regulations
             11.1.3. Price Trend Analysis
             11.1.4. Key Trends
     11.2. Market Value Forecast By Disease Type , 2015–2025
             11.2.1. Topical
             11.2.2. Ocular Insert
                        11.2.2.1. Erodible
                        11.2.2.2. Non-Erodible
             11.2.3. Iontophoresis
             11.2.4. Intraocular Implant
                        11.2.4.1. Biodegradable 
                        11.2.4.2. Non-Biodegradable
             11.2.5. In Situ Gel & Punctal Plug
             11.2.6. Others
     11.3. Market Value Forecast By Formulation Type , 2015–2025
             11.3.1. Solution
             11.3.2. Suspension
             11.3.3. Emulsion
             11.3.4. Liposomes & Nanoparticles
             11.3.5. Ointments
     11.4. Market Value Forecast By Disease Type , 2015–2025
             11.4.1. Diabetic Retinopathy
             11.4.2. Macular Degeneration
             11.4.3. Cataract
             11.4.4. Glaucoma
             11.4.5. Diabetic Macular Edema
             11.4.6. Dry Eye Syndrome
             11.4.7. Others
     11.5. Market Value Forecast By End User , 2015–2025
             11.5.1. Hospitals
             11.5.2. Ambulatory Surgical Centers
             11.5.3. Ophthalmic Clinics
             11.5.4. Homecare Settings
     11.6. Market Value Forecast By Country , 2015–2025
             11.6.1. U.K.
             11.6.2. Germany
             11.6.3. France
             11.6.4. Italy
             11.6.5. Russia
             11.6.6. Spain
             11.6.7. Rest of Europe
     11.7. Market Attractiveness Analysis 
             11.7.1. By Disease Type 
             11.7.2. By Formulation Type 
             11.7.3. By Disease Type 
             11.7.4. By End User 
             11.7.5. By Country

12. Asia Pacific Ocular Drug Delivery Disease Type Market Analysis and Forecast
     12.1. Introduction
             12.1.1. Key Findings
             12.1.2. Policies and Regulations
             12.1.3. Price Trend Analysis
             12.1.4. Key Trends
     12.2. Market Value Forecast By Disease Type , 2015–2025
             12.2.1. Topical
             12.2.2. Ocular Insert
                        12.2.2.1. Erodible
                        12.2.2.2. Non-Erodible
             12.2.3. Iontophoresis
             12.2.4. Intraocular Implant
                        12.2.4.1. Biodegradable 
                        12.2.4.2. Non-Biodegradable
             12.2.5. In Situ Gel & Punctal Plug
             12.2.6. Others
     12.3. Market Value Forecast By Formulation Type , 2015–2025
             12.3.1. Solution
             12.3.2. Suspension
             12.3.3. Emulsion
             12.3.4. Liposomes & Nanoparticles
             12.3.5. Ointments
     12.4. Market Value Forecast By Disease Type , 2015–2025
             12.4.1. Diabetic Retinopathy
             12.4.2. Macular Degeneration
             12.4.3. Cataract
             12.4.4. Glaucoma
             12.4.5. Diabetic Macular Edema
             12.4.6. Dry Eye Syndrome
             12.4.7. Others
     12.5. Market Value Forecast By End User , 2015–2025
             12.5.1. Hospitals
             12.5.2. Ambulatory Surgical Centers
             12.5.3. Ophthalmic Clinics
             12.5.4. Homecare Settings
     12.6. Market Value Forecast By Country , 2015–2025
             12.6.1. China
             12.6.2. Japan
             12.6.3. India
             12.6.4. Australia & New Zealand
             12.6.5. Rest of Asia Pacific
     12.7. Market Attractiveness Analysis 
             12.7.1. By Disease Type 
             12.7.2. By Formulation Type 
             12.7.3. By Disease Type 
             12.7.4. By End User 
             12.7.5. By Country

13. Latin America Ocular Drug Delivery Disease Type Market Analysis and Forecast
     13.1. Introduction
             13.1.1. Key Findings
             13.1.2. Policies and Regulations
             13.1.3. Price Trend Analysis
             13.1.4. Key Trends
     13.2. Market Value Forecast By Disease Type , 2015–2025
             13.2.1. Topical
             13.2.2. Ocular Insert
                        13.2.2.1. Erodible
                        13.2.2.2. Non-Erodible
             13.2.3. Iontophoresis
             13.2.4. Intraocular Implant
                        13.2.4.1. Biodegradable 
                        13.2.4.2. Non-Biodegradable
             13.2.5. In Situ Gel & Punctal Plug
             13.2.6. Others
     13.3. Market Value Forecast By Formulation Type , 2015–2025
             13.3.1. Solution
             13.3.2. Suspension
             13.3.3. Emulsion
             13.3.4. Liposomes & Nanoparticles
             13.3.5. Ointments
     13.4. Market Value Forecast By Disease Type , 2015–2025
             13.4.1. Diabetic Retinopathy
             13.4.2. Macular Degeneration
             13.4.3. Cataract
             13.4.4. Glaucoma
             13.4.5. Diabetic Macular Edema
             13.4.6. Dry Eye Syndrome
             13.4.7. Others
     13.5. Market Value Forecast By End User , 2015–2025
             13.5.1. Hospitals
             13.5.2. Ambulatory Surgical Centers
             13.5.3. Ophthalmic Clinics
             13.5.4. Homecare Settings
     13.6. Market Value Forecast By Country , 2015–2025
             13.6.1. Brazil
             13.6.2. Mexico
             13.6.3. Rest of Latin America
     13.7. Market Attractiveness Analysis 
             13.7.1. By Disease Type 
             13.7.2. By Formulation Type 
             13.7.3. By Disease Type 
             13.7.4. By End User 
             13.7.5. By Country

14. Middle East & Africa Ocular Drug Delivery Disease Type Market Analysis and Forecast
     14.1. Introduction
             14.1.1. Key Findings
             14.1.2. Policies and Regulations
             14.1.3. Price Trend Analysis
             14.1.4. Key Trends
     14.2. Market Value Forecast By Disease Type , 2015–2025
             14.2.1. Topical
             14.2.2. Ocular Insert
                        14.2.2.1. Erodible
                        14.2.2.2. Non-Erodible
             14.2.3. Iontophoresis
             14.2.4. Intraocular Implant
                        14.2.4.1. Biodegradable 
                        14.2.4.2. Non-Biodegradable
             14.2.5. In Situ Gel & Punctal Plug
             14.2.6. Others
     14.3. Market Value Forecast By Formulation Type , 2015–2025
             14.3.1. Solution
             14.3.2. Suspension
             14.3.3. Emulsion
             14.3.4. Liposomes & Nanoparticles
             14.3.5. Ointments
     14.4. Market Value Forecast By Disease Type , 2015–2025
             14.4.1. Diabetic Retinopathy
             14.4.2. Macular Degeneration
             14.4.3. Cataract
             14.4.4. Glaucoma
             14.4.5. Diabetic Macular Edema
             14.4.6. Dry Eye Syndrome
             14.4.7. Others
     14.5. Market Value Forecast By End User , 2015–2025
             14.5.1. Hospitals
             14.5.2. Ambulatory Surgical Centers
             14.5.3. Ophthalmic Clinics
             14.5.4. Homecare Settings
     14.6. Market Value Forecast By Country , 2015–2025
             14.6.1. GCC Countries
             14.6.2. South Africa
             14.6.3. Rest of Middle East and Africa
     14.7. Market Attractiveness Analysis 
             14.7.1. By Disease Type 
             14.7.2. By Formulation Type 
             14.7.3. By Disease Type 
             14.7.4. By End User 
             14.7.5. By Country

15. Competition Landscape
     15.1. Market Player – Competition Matrix (By Tier and Size of companies)
     15.2. Market Share Analysis By Company (2015)
     15.3. Company Profiles 
             15.3.1. OCULAR THERAPEUTIX, INC. 
                        15.3.1.1. Overview
                        15.3.1.2. Financials
                        15.3.1.3. Recent Developments
                        15.3.1.4. Strategy
             15.3.2. Alimera Sciences
                        15.3.2.1. Overview
                        15.3.2.2. Financials
                        15.3.2.3. Recent Developments
                        15.3.2.4. Strategy
             15.3.3. Allergan, Plc 
                        15.3.3.1. Overview
                        15.3.3.2. Financials
                        15.3.3.3. Recent Developments
                        15.3.3.4. Strategy
             15.3.4. Valeant Pharmaceuticals International, Inc. (Bausch & Lomb Incorporated)
                        15.3.4.1. Overview
                        15.3.4.2. Financials
                        15.3.4.3. Recent Developments
                        15.3.4.4. Strategy
             15.3.5. EyeGate Pharma 
                        15.3.5.1. Overview
                        15.3.5.2. Financials
                        15.3.5.3. Recent Developments
                        15.3.5.4. Strategy
             15.3.6. Envisia Therapeutics 
                        15.3.6.1. Overview
                        15.3.6.2. Financials
                        15.3.6.3. Recent Developments
                        15.3.6.4. Strategy
             15.3.7. Clearside Biomedical, INC. 
                        15.3.7.1. Overview
                        15.3.7.2. Financials
                        15.3.7.3. Recent Developments
                        15.3.7.4. Strategy
             15.3.8. Graybug Vision Inc. 
                        15.3.8.1. Overview
                        15.3.8.2. Financials
                        15.3.8.3. Recent Developments
                        15.3.8.4. Strategy
             15.3.9. Santen Pharmaceutical Co., Ltd 
                        15.3.9.1. Overview
                        15.3.9.2. Financials
                        15.3.9.3. Recent Developments
                        15.3.9.4. Strategy
             15.3.10. Taiwan Liposome Company, Ltd
                        15.3.10.1. Overview
                        15.3.10.2. Financials
                        15.3.10.3. Recent Developments
                        15.3.10.4. Strategy 

List of Tables

Table 01: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 02: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
Table 03: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, Intraocular Implants, 2015–2025
Table 04: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
Table 05: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 06: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 07: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 08: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 09: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 10: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
Table 11: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2015–2025
Table 12: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
Table 13: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 14: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 15: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 16: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 17: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
Table 18: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2015–2025
Table 19: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
Table 20: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 21: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End Users, 2015–2025
Table 22: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 23: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 24: Asia Pacific Ocular Drug Delivery Technology Market, by Ocular Inserts, Market Size (US$ Mn) Forecast, 2015–2025
Table 25: Asia Pacific Ocular Drug Delivery Technology Market, by Intraocular Implants, Market Size (US$ Mn) Forecast, 2015–2025
Table 26: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
Table 27: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 28: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End User, 2015–2025
Table 29: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 30: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 31: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
Table 32: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2015–2025
Table 33: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
Table 34: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 35: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End Users, 2015–2025
Table 36: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 37: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 38: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
Table 39: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2015–2025
Table 40: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
Table 41: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 42: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025

List of Figures

Figure 1: Global Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast, 2015–2025
Figure 2: Global Ocular Drug Delivery Technology Market Value Share, by Technology Type (2016)
Figure 3: Global Ocular Drug Delivery Technology Market Value Share, by Formulations Type (2016)
Figure 04: Global Ocular Drug Delivery Technology Market Value Share, by Disease Type (2016)
Figure 05: Global Ocular Drug Delivery Technology Market Value Share, by Region (2016)
Figure 06: Global Ocular Drug Delivery Technology Market Value Share, by End-user (2016)
Figure 07: Global Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
Figure 08: Global Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017–2025
Figure 09: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Topical, 2015–2025
Figure 10: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ocular Inserts, 2015–2025
Figure 11: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Iontophoresis, 2015–2025
Figure 12: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Intraocular Implants, 2015–2025
Figure 13: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by In Situ Gel & Punctal Plugs, 2015–2025
Figure 14: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Other Technology, 2015–2025
Figure 15: Global Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
Figure 16: Global Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017–2025
Figure 17: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Suspension, 2015–2025
Figure 18: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Solution, 2015–2025
Figure 19: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Liposome & Nanoparticle, 2015–2025
Figure 20: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Emulsion, 2015–2025
Figure 21: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Ointment, 2015–2025
Figure 22: Global Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
Figure 23: Global Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017–2025
Figure 24: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Glaucoma, 2015–2025
Figure 25: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diabetic Retinopathy, 2015–2025
Figure 26: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Dry Eye Syndrome, 2015–2025
Figure 27: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Macular Degeneration, 2015–2025
Figure 28: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diabetic Macular Edema, 2015–2025
Figure 29: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cataract, 2015–2025
Figure 30: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2015–2025
Figure 31: Global Ocular Drug Delivery Technology Market Value Share, by End-user, 2017 and 2025
Figure 32: Global Ocular Drug Delivery Technology Market Attractiveness, by End-user, 2017–2025
Figure 33: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2015–2025
Figure 34: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by ASCs, 2015–2025
Figure 35: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ophthalmic Clinics, 2015–2025
Figure 36: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Home Care Settings, 2015–2025
Figure 37: Global Ocular Drug Delivery Technology Market Value Share, by Region, 2017 and 2025 
Figure 38: Global Ocular Drug Delivery Technology Market Attractiveness, by Region, 2017–2025
Figure 39: North America Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 40: North America Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
Figure 41: North America Ocular Drug Delivery Technology Market Attractiveness, 2017–2025
Figure 42: North America Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
Figure 43: North America Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017–2025
Figure 44: North America Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
Figure 45: North America Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017–2025
Figure 46: North America Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
Figure 47: North America Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017–2025
Figure 48: North America Ocular Drug Delivery Technology Market Value Share, by End-user, 2017 and 2025
Figure 49: North America Ocular Drug Delivery Technology Market Attractiveness, by End-user, 2017–2025
Figure 50: Europe Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 51: Europe Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
Figure 52: Europe Ocular Drug Delivery Technology Market Attractiveness, by Country, 2017–2025
Figure 53: Europe Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
Figure 54: Europe Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017-2025
Figure 55: Europe Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
Figure 56: Europe Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017-2025
Figure 57: Europe Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
Figure 58: Europe Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017-2025
Figure 59: Europe Ocular Drug Delivery Technology Market Value Share, by End Users, 2017 and 2025
Figure 60: Europe Ocular Drug Delivery Technology Market Attractiveness, by End Users, 2017-2025
Figure 61: Asia Pacific Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 62: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
Figure 63: Asia Pacific Ocular Drug Delivery Technology, Market Attractiveness, by Country, 2017–2025
Figure 64: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
Figure 65: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017-2025
Figure 66: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
Figure 67: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017-2025
Figure 68: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
Figure 69: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017-2025
Figure 70: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by End User, 2017 and 2025
Figure 71: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by End User, 2017–2025
Figure 72: Latin America Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 73: Latin America Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
Figure 74: Latin America Ocular Drug Delivery Technology, Market Attractiveness, by Country, 2017–2025
Figure 75: Latin America Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
Figure 76: Latin America Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017-2025
Figure 77: Latin America Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
Figure 78: Latin America Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017–2025
Figure 79: Latin America Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
Figure 80: Latin America Ocular Drug Delivery Technology  Market Attractiveness, by Disease Type, 2017-2025
Figure 81: Latin America Ocular Drug Delivery Technology Market Value Share, by End Users, 2017 and 2025
Figure 82: Latin America Ocular Drug Delivery Technology Market Attractiveness, by End Users, 2017–2025
Figure 83: Middle East & Africa Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 84: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
Figure 85: Middle East & Africa Ocular Drug Delivery Technology, Market Attractiveness, by Country, 2017–2025
Figure 86: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
Figure 87: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017–2025
Figure 88: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
Figure 89: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017-2025
Figure 90: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
Figure 91: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017–2025
Figure 92: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by End-user, 2017 and 2025
Figure 93: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by End-user, 2017–2025
Figure 94: Global Ocular Drug Delivery Technology  Market Share, by Company, 2016

.